| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Gilead Sciences, Inc. (GILD) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. GILD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 626.3K | $79.13M | -15,000 | |
| Other | 46.9K | $5.93M | - | |
| Other | 46.6K | $5.89M | - | |
| VP | 44.2K | $5.58M | - | |
| Other | 27.9K | $3.52M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2023 | Parsey Merdad52 | Chief Medical Officer | Sell | 6,126 | $78.99 | $483,892.74 | -8.0% | -2.1% | -5.6% | |
| Mar 1, 2023 | Parsey Merdad52 | Chief Medical Officer | Sell | 12,984 | $79.96 | $1,038,225.31 | -15.6% | -4.1% | -9.4% | |
| Dec 30, 2022 | Parsey Merdad52 | Chief Medical Officer | Sell | 553 | $85.33 | $47,187.49 | -1.2% | -5.1% | -5.6% | |
| Nov 9, 2022 | Wilfong Diane E.48 | SVP, Controller &CAO | Sale+OE | 6,416 | $83.50 | $535,736.00 | -18.5% | +5.4% | -8.2% | |
| Nov 1, 2022 | Wilfong Diane E.48 | SVP, Controller &CAO | Sale+OE | 16,255 | $79.25 | $1,288,208.75 | -36.5% | +5.9% | +1.9% | |
| Mar 11, 2022 | Pletcher Brett A | EVP,Corp Affairs &Gen Counsel | Sale+OE | 3,634 | $58.24 | $211,644.16 | -10.0% | +6.8% | +43.3% | |
| Feb 9, 2022 | Pletcher Brett A | EVP,Corp Affairs &Gen Counsel | Sell | 1,691 | $63.89 | $108,037.99 | -4.9% | -1.3% | +41.1% | |
| Feb 1, 2022 | Pletcher Brett A | EVP,Corp Affairs &Gen Counsel | Sell | 14,061 | $68.54 | $963,681.88 | -30.1% | -10.8% | +28.3% | |
| Aug 17, 2021 | Wilfong Diane E.48 | SVP, Controller &CAO | Sale+OE | 13,610 | $72.50 | $986,725.00 | -40.0% | -7.1% | -5.4% | |
| May 4, 2021 | Mercier Johanna | Chief Commercial Officer | Sell | 19,496 | $66.09 | $1,288,547.18 | -70.7% | +5.2% | -1.3% |